Publications - July 2021

Preprint and peer-reviewed publications from RECOVER’s studies

Following the science? Views from scientists on government advisory boards during the COVID-19 pandemic: a qualitative interview study in five European countries (Colman et al. 2021)

Future pandemic preparedness efforts should focus on building
interdisciplinary collaboration within advisory boards; ensuring transparency in how boards operate;
defining and protecting boundaries of the scientific advisor role; and supporting scientists to inform
the public in the fight against disinformation, whilst dealing with potential hostile reactions.

Read article

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial (Arabi et al. 2021)

This study investigates the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with COVID-19. Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control). The results show that, among critically ill patients with COVID-19, lopinavir-ritonavir, hydroxychloroquine, or combination therapy worsened outcomes compared to no antiviral therapy.

Read article